Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NORDTHY FYSIOTERAPI, AUTORISEREDE FYSIOTERAPEUTER ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   1.6% 1.9% 1.3% 1.1% 1.1% 0.8% 6.4% 6.4%   Credit score (0-100)   77 72 80 83 85 90 37 37   Credit rating   A A A A A AA BBB BBB   Credit limit (kDKK)   8.7 1.5 70.8 151.6 215.4 572.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   6,410 6,598 5,138 6,684 7,279 8,953 0.0 0.0   EBITDA   1,564 1,684 1,148 1,091 972 1,675 0.0 0.0   EBIT   1,298 1,505 989 932 664 1,290 0.0 0.0   Pre-tax profit (PTP)   1,293.1 1,508.8 979.9 928.3 630.6 1,201.7 0.0 0.0   Net earnings   1,005.2 1,174.8 762.1 726.8 490.1 933.9 0.0 0.0   Pre-tax profit without non-rec. items   1,293 1,509 980 928 631 1,202 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   610 472 363 1,579 2,494 1,161 0.0 0.0   Shareholders equity total   1,723 1,998 2,160 2,286 2,777 3,710 3,585 3,585   Interest-bearing liabilities   0.0 0.0 0.0 0.0 1,925 1,775 0.0 0.0   Balance sheet total (assets)   2,292 2,437 3,078 3,160 5,349 6,405 3,585 3,585   Net Debt   -692 -1,195 -1,869 -274 1,748 422 -2,070 -2,070     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   6,410 6,598 5,138 6,684 7,279 8,953 0.0 0.0   Gross profit growth   38.8% 2.9% -22.1% 30.1% 8.9% 23.0% -100.0% 0.0%   Employees   11 11 11 12 14 15 0 0   Employee growth %   0.0% 0.0% 0.0% 9.1% 16.7% 7.1% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,292 2,437 3,078 3,160 5,349 6,405 3,585 3,585   Balance sheet change%   -3.2% 6.3% 26.3% 2.6% 69.3% 19.8% -44.0% 0.0%   Added value   1,564.5 1,684.2 1,148.3 1,091.5 823.9 1,675.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -96 -317 -269 1,057 2,302 -1,898 -1,161 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   20.3% 22.8% 19.2% 13.9% 9.1% 14.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   55.8% 63.9% 36.1% 30.1% 15.8% 22.5% 0.0% 0.0%   ROI %   74.3% 81.3% 46.7% 41.2% 19.0% 25.5% 0.0% 0.0%   ROE %   57.6% 63.2% 36.7% 32.7% 19.4% 28.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   75.5% 82.4% 70.3% 72.4% 51.9% 58.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -44.2% -71.0% -162.8% -25.1% 179.8% 25.2% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 69.3% 47.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 4.3% 6.5% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.7 4.2 3.2 1.6 1.4 3.6 0.0 0.0   Current Ratio   2.7 4.1 3.1 1.6 1.4 3.6 0.0 0.0   Cash and cash equivalent   692.1 1,195.0 1,869.1 274.2 177.2 1,353.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   951.8 1,364.1 1,738.5 545.8 283.7 2,577.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   142 153 104 91 59 112 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   142 153 104 91 69 112 0 0   EBIT / employee   118 137 90 78 47 86 0 0   Net earnings / employee   91 107 69 61 35 62 0 0